Connecting Cancer Researchers and Advocates: The Importance of Regeneration
By Bob Riter, Patient Advocate, Cornell Community Cancer Partnership When I was diagnosed with stage 2 breast cancer about...
By Bob Riter, Patient Advocate, Cornell Community Cancer Partnership When I was diagnosed with stage 2 breast cancer about...
Patient advocates at the AACR Annual meeting 2024 brought their perspectives to cancer researchers.
Editor’s note: As we honor National Cancer Survivor Month, we are also recognizing the AACR Scientist↔Survivor Program’s positive impact...
Gregory J. Aune, MD, PhD, is a renowned pediatric oncologist with a powerful story. At age 16, he was...
For more than 20 years, the Scientist↔Survivor Program (SSP) has played a vital role in the American Association for...
In the ongoing quest to end cancer health disparities, there’s a simple tool that virtually anyone can use: honest...
Multiple myeloma is a cancer of antibody-producing cells—called plasma cells—that accounts for approximately 1.8 percent of new cancer cases...
The 12th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved kicked...
Cancer patient advocates take on many roles in their communities. They may go out to churches to promote the...
When Michael Lawing was diagnosed with stage 3 renal cell carcinoma in 1997, he knew almost nothing about the...